Scarsdale Synagogue/ Tremont Temple – Trademark Portfolio

Entity Type: 99

Scarsdale Synagogue/ Tremont Temple holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MAZEL TOTS. The owner is based in Scarsdale, NY.

Two Ogden Road

Scarsdale, NY 10583

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Scarsdale Synagogue/ Tremont Temple's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Scarsdale Synagogue/ Tremont Temple have?

Scarsdale Synagogue/ Tremont Temple has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Scarsdale Synagogue/ Tremont Temple file in?

Scarsdale Synagogue/ Tremont Temple files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 41 (Education & Entertainment). Class 25 covers clothing, footwear, headgear.

What are Scarsdale Synagogue/ Tremont Temple's most well-known trademarks?

Scarsdale Synagogue/ Tremont Temple's registered trademark portfolio includes well-known marks such as MAZEL TOTS. These are among 1 currently registered trademark in the portfolio.

What is Scarsdale Synagogue/ Tremont Temple's trademark registration success rate?

Scarsdale Synagogue/ Tremont Temple has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.